We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current NKTX market cap is 155.96M. The company's latest EPS is USD -1.6651 and P/E is -1.33.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -29.29M | -31.19M | -32.76M | -30.72M | -33.79M |
| Net Income | -25.65M | -27.75M | -29.52M | -24.99M | -28.34M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 115k | 0 | 0 | 0 | 0 |
| Operating Income | -22.35M | -51.51M | -86.43M | -118.96M | -131.65M |
| Net Income | -21.08M | -91.36M | -86.08M | -113.84M | -117.5M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 405.86M | 378.89M | 576.94M | 554.09M | 532.03M |
| Total Liabilities | 109.05M | 105.6M | 103.29M | 100.9M | 101.16M |
| Total Equity | 296.82M | 273.29M | 473.65M | 453.18M | 430.87M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 48.41M | 337.65M | 273.9M | 472.94M | 378.89M |
| Total Liabilities | 14.08M | 16.43M | 22.94M | 100.73M | 105.6M |
| Total Equity | -25.48M | 321.22M | 250.97M | 372.21M | 273.29M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -62.81M | -86.16M | -28.51M | -50.4M | -74.95M |
| Investing | 63.18M | 79.02M | 21.49M | -86.14M | -125.04M |
| Financing | 396k | 691k | 226.27M | 225.9M | 225.9M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -18.37M | -43.51M | -67.93M | -57M | -86.16M |
| Investing | -18.3M | -210.08M | 32.53M | -184.69M | 79.02M |
| Financing | 49.58M | 329.82M | 1.2M | 219.01M | 691k |
| Market Cap | 155.96M |
| Price to Earnings Ratio | -1.33 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 5.02 |
| Price to Book Ratio | 0.57 |
| Dividend Yield | - |
| Shares Outstanding | 70.57M |
| Average Volume (1 week) | 1.16M |
| Average Volume (1 Month) | 1.49M |
| 52 Week Change | -74.71% |
| 52 Week High | 16.24 |
| 52 Week Low | 2.08 |
| Spread (Intraday) | 0.32 (12.8%) |
| Company Name | Nkarta Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https:// |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
